BIOS Advisors GP, LLC
Insider CIK 1813844 · CGTX Director, 10% owner · ACTU Director, 10% owner · AZTR 10% owner · INAB Director, 10% owner · LTRN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGTX COGNITION THERAPEUTICS INC | A Award | 2026-06-17 | 2026-06-22 | 25,000 | — | $0 | 81,229 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | P Buy deriv | 2025-06-27 | 2025-06-30 | 71,428 | — | $0 | 71,428 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | P Buy | 2025-06-27 | 2025-06-30 | 71,428 | $7.00 | $500.0K | 196,428 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | A Award | 2025-06-18 | 2025-06-20 | 34,000 | — | $0 | 48,500 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-13 | 2025-06-13 | 7,206 | $3.09 | $22.3K | 189,117 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-13 | 2025-06-13 | 14,218 | $3.09 | $43.9K | 373,178 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-13 | 2025-06-13 | 1,903 | $3.09 | $5.9K | 49,957 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-13 | 2025-06-13 | 4,354 | $3.09 | $13.5K | 114,272 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-13 | 2025-06-13 | 12,319 | $3.09 | $38.1K | 323,335 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-12 | 2025-06-13 | 18,678 | $3.38 | $63.1K | 335,654 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-12 | 2025-06-13 | 2,886 | $3.38 | $9.8K | 51,860 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-12 | 2025-06-13 | 21,557 | $3.38 | $72.9K | 387,396 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-12 | 2025-06-13 | 6,601 | $3.38 | $22.3K | 118,626 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-12 | 2025-06-13 | 10,925 | $3.38 | $36.9K | 196,323 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-11 | 2025-06-13 | 293 | $3.40 | $996 | 354,332 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-11 | 2025-06-13 | 45 | $3.40 | $153 | 54,746 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-11 | 2025-06-13 | 338 | $3.40 | $1.1K | 408,953 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-11 | 2025-06-13 | 103 | $3.40 | $350 | 125,227 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-11 | 2025-06-13 | 171 | $3.40 | $581 | 207,248 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-10 | 2025-06-13 | 5 | $3.40 | $17 | 409,291 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-10 | 2025-06-13 | 2 | $3.40 | $7 | 125,330 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-10 | 2025-06-13 | 3 | $3.40 | $10 | 207,419 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-10 | 2025-06-13 | 5 | $3.40 | $17 | 354,625 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-06-10 | 2025-06-13 | 1 | $3.40 | $3 | 54,791 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-29 | 2025-05-29 | 3,639 | $3.03 | $11.0K | 207,422 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-29 | 2025-05-29 | 6,221 | $3.03 | $18.8K | 354,630 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-29 | 2025-05-29 | 961 | $3.03 | $2.9K | 54,792 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-29 | 2025-05-29 | 7,180 | $3.03 | $21.8K | 409,296 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-29 | 2025-05-29 | 2,199 | $3.03 | $6.7K | 125,332 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-28 | 2025-05-29 | 1,632 | $2.87 | $4.7K | 127,531 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-28 | 2025-05-29 | 2,702 | $2.87 | $7.8K | 211,061 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-28 | 2025-05-29 | 4,620 | $2.87 | $13.3K | 360,851 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-28 | 2025-05-29 | 714 | $2.87 | $2.0K | 55,753 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-28 | 2025-05-29 | 5,332 | $2.87 | $15.3K | 416,476 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-27 | 2025-05-29 | 6,479 | $3.05 | $19.8K | 365,471 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-27 | 2025-05-29 | 1,000 | $3.05 | $3.0K | 56,467 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-27 | 2025-05-29 | 7,478 | $3.05 | $22.8K | 421,808 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-27 | 2025-05-29 | 2,290 | $3.05 | $7.0K | 129,163 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2025-05-27 | 2025-05-29 | 3,790 | $3.05 | $11.6K | 213,763 | SEC↗ |
| [INAB IN8BIO, INC. | P Buy deriv | 2025-05-02 | 2025-05-07 | 1,148,482 | — | $0 | 2,431,763 | SEC↗ |
| [INAB IN8BIO, INC. | J Other deriv | 2025-05-02 | 2025-05-07 | 574,241 | — | $0 | 0 | SEC↗ |
| [INAB IN8BIO, INC. | J Other deriv | 2025-05-02 | 2025-05-07 | 574,241 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | P Buy deriv | 2024-10-04 | 2024-10-11 | 709,040 | — | $0 | 1,283,281 | SEC↗ |
| INAB IN8BIO, INC. | P Buy deriv | 2024-10-04 | 2024-10-11 | 709,040 | — | $0 | 709,040 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2024-10-04 | 2024-10-11 | 574,241 | — | $0 | 574,241 | SEC↗ |
| INAB IN8BIO, INC. | D To issuer deriv | 2024-10-04 | 2024-10-11 | 574,241 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | X Exercise deriv | 2024-08-14 | 2024-08-14 | 3,528 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | X Exercise deriv | 2024-08-14 | 2024-08-14 | 26,355 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | X Exercise deriv | 2024-08-14 | 2024-08-14 | 8,068 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 573,394 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 78,267 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 484,638 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 74,202 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 2,094,650 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 326,547 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 2,022,029 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 309,589 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 44,559 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 332,867 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 101,900 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 147,047 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 23,628 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 176,499 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 54,032 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 153,702 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 61,857 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 462,073 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 141,457 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 307,538 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 525,797 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion deriv | 2024-08-14 | 2024-08-14 | 884,427 | — | $0 | 0 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | P Buy | 2024-08-14 | 2024-08-14 | 375,000 | $8.00 | $3.00M | 1,259,427 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | X Exercise | 2024-08-14 | 2024-08-14 | 3,528 | $5.27 | $18.6K | 133,572 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | S Sale | 2024-08-14 | 2024-08-14 | 17,361 | $9.00 | $156.2K | 980,433 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | X Exercise | 2024-08-14 | 2024-08-14 | 26,355 | $5.27 | $138.9K | 997,794 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | S Sale | 2024-08-14 | 2024-08-14 | 5,314 | $9.00 | $47.8K | 300,143 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | X Exercise | 2024-08-14 | 2024-08-14 | 8,068 | $5.27 | $42.5K | 305,457 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 573,394 | — | $0 | 573,394 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 78,267 | — | $0 | 404,814 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 484,638 | — | $0 | 2,506,667 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 74,202 | — | $0 | 383,791 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 2,094,650 | — | $0 | 2,094,650 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 326,547 | — | $0 | 326,547 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 2,022,029 | — | $0 | 2,022,029 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 309,589 | — | $0 | 309,589 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 44,559 | — | $0 | 130,044 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 332,867 | — | $0 | 971,439 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 101,900 | — | $0 | 297,389 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 147,047 | — | $0 | 300,749 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 23,628 | — | $0 | 85,485 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 176,499 | — | $0 | 638,572 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 54,032 | — | $0 | 195,489 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 153,702 | — | $0 | 153,702 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 61,857 | — | $0 | 61,857 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 462,073 | — | $0 | 462,073 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 141,457 | — | $0 | 141,457 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 307,538 | — | $0 | 307,538 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 525,797 | — | $0 | 525,797 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | P Buy | 2024-08-14 | 2024-08-14 | 125,000 | $8.00 | $1.00M | 125,000 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | S Sale | 2024-08-14 | 2024-08-14 | 2,324 | $9.00 | $20.9K | 131,248 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | C Conversion | 2024-08-14 | 2024-08-14 | 884,427 | — | $0 | 884,427 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | S Sale | 2024-08-14 | 2024-08-20 | 17,361 | $8.00 | $138.9K | 980,433 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | S Sale | 2024-08-14 | 2024-08-20 | 5,314 | $8.00 | $42.5K | 300,143 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | S Sale | 2024-08-14 | 2024-08-20 | 2,324 | $8.00 | $18.6K | 131,248 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2024-08-12 | 2024-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 14,500 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-05-24 | 2024-05-28 | 1,859 | $6.33 | $11.8K | 57,467 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-05-24 | 2024-05-28 | 13,888 | $6.33 | $87.9K | 429,286 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-05-24 | 2024-05-28 | 4,253 | $6.33 | $26.9K | 131,453 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-05-23 | 2024-05-28 | 6,944 | $6.25 | $43.4K | 443,174 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-05-23 | 2024-05-28 | 2,126 | $6.25 | $13.3K | 135,706 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-05-23 | 2024-05-28 | 930 | $6.25 | $5.8K | 59,326 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-29 | 2024-02-29 | 4,185 | $4.87 | $20.4K | 137,832 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-29 | 2024-02-29 | 13,686 | $4.87 | $66.7K | 450,118 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-29 | 2024-02-29 | 1,832 | $4.87 | $8.9K | 60,256 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-28 | 2024-02-29 | 15,780 | $4.85 | $76.5K | 142,017 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-28 | 2024-02-29 | 6,909 | $4.85 | $33.5K | 62,088 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-28 | 2024-02-29 | 51,608 | $4.85 | $250.3K | 463,804 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-27 | 2024-02-29 | 34,731 | $4.40 | $152.8K | 515,412 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-27 | 2024-02-29 | 4,649 | $4.40 | $20.5K | 68,997 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-02-27 | 2024-02-29 | 10,620 | $4.40 | $46.7K | 157,797 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2024-01-17 | 2024-01-19 | 16,801 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2024-01-17 | 2024-01-19 | 7,347 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2024-01-17 | 2024-01-19 | 54,873 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-01-17 | 2024-01-19 | 5,475 | $4.20 | $23.0K | 73,646 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2024-01-17 | 2024-01-19 | 16,801 | $3.13 | $52.6K | 180,938 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-01-17 | 2024-01-19 | 40,893 | $4.20 | $171.8K | 550,143 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2024-01-17 | 2024-01-19 | 7,347 | $3.13 | $23.0K | 79,121 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2024-01-17 | 2024-01-19 | 54,873 | $3.13 | $171.8K | 591,036 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2024-01-17 | 2024-01-19 | 12,521 | $4.20 | $52.6K | 168,417 | SEC↗ |
| NGE C IN8BIO, INC. | P Buy deriv | 2023-12-13 | 2023-12-14 | 574,241 | — | $0 | 574,241 | SEC↗ |
| NGE C IN8BIO, INC. | P Buy deriv | 2023-12-13 | 2023-12-14 | 574,241 | — | $0 | 574,241 | SEC↗ |
| NGE C IN8BIO, INC. | P Buy deriv | 2023-12-13 | 2023-12-14 | 574,241 | — | $0 | 574,241 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2023-11-29 | 2023-12-01 | 91,708 | $3.44 | $315.5K | 371,950 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2023-11-29 | 2023-12-01 | 53,640 | $3.44 | $184.5K | 217,553 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | A Award | 2023-11-08 | 2023-11-13 | 500,095 | $1.05 | $525.1K | 500,095 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 397,600 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 123,718 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 808,058 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 130,498 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 467,613 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 799,467 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 232,908 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 52,078 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 412,389 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 170,272 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 101,842 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion deriv | 2023-06-21 | 2023-06-23 | 22,798 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 436,173 | — | $0 | 436,173 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 25,280 | — | $0 | 137,000 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 111,720 | — | $0 | 111,720 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 188,810 | — | $0 | 1,023,442 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 834,632 | — | $0 | 834,632 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 57,747 | — | $0 | 313,250 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 255,503 | — | $0 | 255,503 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 799,467 | — | $0 | 799,467 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 467,613 | — | $0 | 467,613 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 144,705 | — | $0 | 426,944 | SEC↗ |
| AZTR Azitra Inc | P Buy | 2023-06-21 | 2023-06-23 | 73,708 | $5.00 | $368.5K | 282,239 | SEC↗ |
| AZTR Azitra Inc | P Buy | 2023-06-21 | 2023-06-23 | 208,531 | — | $0 | 208,531 | SEC↗ |
| AZTR Azitra Inc | S Sale | 2023-06-21 | 2023-06-23 | 82,223 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 896,035 | — | $0 | 2,643,705 | SEC↗ |
| AZTR Azitra Inc | P Buy | 2023-06-21 | 2023-06-23 | 456,412 | $5.00 | $2.28M | 1,747,670 | SEC↗ |
| AZTR Azitra Inc | P Buy | 2023-06-21 | 2023-06-23 | 1,291,258 | — | $0 | 1,291,258 | SEC↗ |
| AZTR Azitra Inc | S Sale | 2023-06-21 | 2023-06-23 | 509,141 | — | $0 | 0 | SEC↗ |
| AZTR Azitra Inc | C Conversion | 2023-06-21 | 2023-06-23 | 137,186 | — | $0 | 404,767 | SEC↗ |
| AZTR Azitra Inc | P Buy | 2023-06-21 | 2023-06-23 | 69,880 | $5.00 | $349.4K | 267,581 | SEC↗ |
| AZTR Azitra Inc | P Buy | 2023-06-21 | 2023-06-23 | 197,701 | — | $0 | 197,701 | SEC↗ |
| AZTR Azitra Inc | S Sale | 2023-06-21 | 2023-06-23 | 77,953 | — | $0 | 0 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-12-12 | 2022-12-13 | 8,735 | $2.48 | $21.7K | 570,724 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-12-12 | 2022-12-13 | 9,214 | $2.48 | $22.9K | 601,980 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-12-12 | 2022-12-13 | 57,052 | $2.48 | $141.5K | 3,727,597 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-28 | 2022-11-29 | 1,973 | $2.65 | $5.2K | 326,733 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-28 | 2022-11-29 | 12,220 | $2.65 | $32.4K | 2,021,906 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-28 | 2022-11-29 | 1,871 | $2.65 | $5.0K | 309,748 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-16 | 2022-11-17 | 8,722 | $1.40 | $12.2K | 324,760 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-16 | 2022-11-17 | 54,009 | $1.40 | $75.6K | 2,009,686 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-16 | 2022-11-17 | 8,269 | $1.40 | $11.6K | 307,877 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-15 | 2022-11-16 | 184,270 | $1.20 | $221.1K | 316,038 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-15 | 2022-11-16 | 174,700 | $1.20 | $209.6K | 299,608 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | P Buy | 2022-11-15 | 2022-11-16 | 1,141,030 | $1.20 | $1.37M | 1,955,677 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-11-08 | 2022-11-09 | 17,748 | $4.40 | $78.1K | 71,774 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-11-08 | 2022-11-09 | 132,575 | $4.40 | $583.3K | 536,163 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-11-08 | 2022-11-09 | 40,586 | $4.40 | $178.6K | 164,137 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-11-08 | 2022-11-09 | 58,711 | $4.40 | $258.3K | 271,193 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-11-08 | 2022-11-09 | 100,380 | $4.40 | $441.7K | 463,658 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-09-28 | 2022-09-29 | 2,913 | $2.02 | $5.9K | 561,989 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-09-28 | 2022-09-29 | 19,017 | $2.02 | $38.4K | 3,670,545 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-09-28 | 2022-09-29 | 3,070 | $2.02 | $6.2K | 592,766 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2022-09-02 | 2022-09-07 | 6,438 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2022-09-02 | 2022-09-07 | 26,100 | — | $0 | 6,438 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2022-09-02 | 2022-09-07 | 26,100 | $1.03 | $26.9K | 26,100 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-09-02 | 2022-09-07 | 5,170 | $5.20 | $26.9K | 20,930 | SEC↗ |
| LTRN Lantern Pharma Inc. | S Sale | 2022-09-02 | 2022-09-07 | 1,275 | $5.20 | $6.6K | 26,093 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2022-09-02 | 2022-09-07 | 6,438 | $1.03 | $6.6K | 27,328 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-17 | 2022-08-18 | 38,035 | $1.93 | $73.4K | 3,612,569 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-17 | 2022-08-18 | 5,823 | $1.93 | $11.2K | 553,110 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-17 | 2022-08-18 | 6,142 | $1.93 | $11.9K | 583,407 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-16 | 2022-08-17 | 206,575 | $1.90 | $392.5K | 540,287 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-16 | 2022-08-17 | 217,891 | $1.90 | $414.0K | 217,891 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-16 | 2022-08-17 | 1,349,218 | $1.90 | $2.56M | 3,574,534 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-06-10 | 2022-06-14 | 8,335 | — | $0 | 11,054 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-06-10 | 2022-06-14 | 2,469 | — | $0 | 8,585 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-06-10 | 2022-06-14 | 2,469 | — | $0 | 3,614 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-06-10 | 2022-06-30 | 2,469 | — | $0 | 8,585 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-06-10 | 2022-06-30 | 2,469 | — | $0 | 3,614 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-06-10 | 2022-06-30 | 8,335 | — | $0 | 11,054 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2022-03-17 | 2022-03-21 | 60,432 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2022-03-17 | 2022-03-21 | 35,347 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2022-03-17 | 2022-03-21 | 60,432 | $189152.16 | $11.43B | 564,038 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2022-03-17 | 2022-03-21 | 35,347 | $110636.11 | $3.91B | 329,904 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-01-31 | 2022-02-01 | 1,145 | — | $0 | 2,719 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | J Other deriv | 2022-01-31 | 2022-02-01 | 1,145 | — | $0 | 1,145 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| CGTX COGNITION THERAPEUTICS INC | C Conversion | 2021-10-13 | 2022-02-01 | 1,424,014 | — | $0 | 1,424,014 | SEC↗ |
| INAB IN8BIO, INC. | J Other deriv | 2021-08-13 | 2021-08-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| INAB IN8BIO, INC. | J Other deriv | 2021-08-13 | 2021-08-17 | 12,775 | — | $0 | 12,775 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 309,823 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 907,007 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 1,706,490 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 522,355 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 2,023,568 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 326,795 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 228,438 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 359,374 | — | $0 | 359,374 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 2,225,316 | — | $0 | 2,225,316 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 1,876,624 | — | $0 | 1,876,624 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 251,211 | — | $0 | 251,211 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 997,433 | — | $0 | 997,433 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 340,712 | — | $0 | 340,712 | SEC↗ |
| INAB IN8BIO, INC. | C Conversion | 2021-08-03 | 2021-08-03 | 574,432 | — | $0 | 574,432 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion deriv | 2020-06-15 | 2020-06-16 | 35,181 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | J Other deriv | 2020-06-15 | 2020-06-16 | 9,135 | — | $0 | 9,135 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion deriv | 2020-06-15 | 2020-06-16 | 80,454 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion deriv | 2020-06-15 | 2020-06-16 | 169,286 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion deriv | 2020-06-15 | 2020-06-16 | 262,806 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion deriv | 2020-06-15 | 2020-06-16 | 289,429 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion | 2020-06-15 | 2020-06-16 | 139,989 | — | $0 | 204,723 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion | 2020-06-15 | 2020-06-16 | 457,282 | — | $0 | 668,738 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion | 2020-06-15 | 2020-06-16 | 61,214 | — | $0 | 89,522 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion | 2020-06-15 | 2020-06-16 | 294,557 | — | $0 | 294,557 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion | 2020-06-15 | 2020-06-16 | 503,606 | — | $0 | 503,606 | SEC↗ |